Elanco Animal Health Financial Statements (ELAN)
|
|
|
|
Report date
|
|
|
28.02.2022 |
01.03.2023 |
26.02.2024 |
25.02.2025 |
24.02.2026 |
|
06.05.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
4 764 |
4 411 |
4 417 |
4 439 |
4 715 |
|
4 893 |
|
Operating Income, bln rub |
|
|
304.0 |
384.0 |
326.0 |
251.0 |
252.0 |
|
438.0 |
|
EBITDA, bln rub |
? |
|
409.0 |
866.0 |
-224.0 |
1 489 |
676.0 |
|
755.0 |
|
Net profit, bln rub |
? |
|
-483.0 |
-78.0 |
-1 231 |
338.0 |
-232.0 |
|
-242.0 |
|
|
OCF, bln rub |
? |
|
483.0 |
452.0 |
271.0 |
541.0 |
560.0 |
|
577.0 |
|
CAPEX, bln rub |
? |
|
197.0 |
184.0 |
154.0 |
147.0 |
276.0 |
|
262.0 |
|
FCF, bln rub |
? |
|
286.0 |
268.0 |
117.0 |
394.0 |
284.0 |
|
315.0 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
|
|
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
OPEX, bln rub |
|
|
1 772 |
1 586 |
1 612 |
1 658 |
1 798 |
|
1 981 |
|
Cost of production, bln rub |
|
|
2 688 |
2 441 |
2 479 |
2 530 |
2 665 |
|
2 474 |
|
R&D, bln rub |
|
|
369.0 |
321.0 |
327.0 |
344.0 |
368.0 |
|
371.0 |
|
Interest expenses, bln rub |
|
|
264.0 |
256.0 |
277.0 |
339.0 |
220.0 |
|
270.0 |
|
|
Assets, bln rub |
|
|
16 478 |
15 491 |
14 362 |
12 614 |
13 358 |
|
13 222 |
|
Net Assets, bln rub |
? |
|
7 508 |
7 289 |
6 223 |
6 096 |
6 547 |
|
6 500 |
|
Debt, bln rub |
|
|
6 319 |
5 836 |
5 774 |
4 321 |
4 017 |
|
3 991 |
|
Cash, bln rub |
|
|
638.0 |
345.0 |
352.0 |
468.0 |
545.0 |
|
428.0 |
|
Net debt, bln rub |
|
|
5 681 |
5 491 |
5 422 |
3 853 |
3 472 |
|
3 563 |
|
|
Ordinary share price, rub |
|
|
28.4 |
|
|
12.1 |
22.6 |
|
21.7 |
|
Number of ordinary shares, mln |
|
|
487.2 |
488.3 |
492.3 |
494.0 |
496.4 |
|
497.7 |
|
|
Market cap, bln rub |
|
|
13 827 |
0 |
0 |
5 982 |
11 234 |
|
10 805 |
|
EV, bln rub |
? |
|
19 508 |
5 491 |
5 422 |
9 835 |
14 706 |
|
14 368 |
|
Book value, bln rub |
|
|
-4 251 |
-3 546 |
-3 365 |
-1 999 |
-1 640 |
|
-1 448 |
|
|
EPS, rub |
? |
|
-0.99 |
-0.16 |
-2.50 |
0.68 |
-0.47 |
|
-0.49 |
|
FCF/share, rub |
|
|
0.59 |
0.55 |
0.24 |
0.80 |
0.57 |
|
0.63 |
|
BV/share, rub |
|
|
-8.73 |
-7.26 |
-6.84 |
-4.05 |
-3.30 |
|
-2.91 |
|
|
EBITDA margin, % |
? |
|
8.59% |
19.6% |
-5.07% |
33.5% |
14.3% |
|
15.4% |
|
Net margin, % |
? |
|
-10.1% |
-1.77% |
-27.9% |
7.61% |
-4.92% |
|
-4.95% |
|
FCF yield, % |
? |
|
2.07% |
|
|
6.59% |
2.53% |
|
2.92% |
|
ROE, % |
? |
|
-6.43% |
-1.07% |
-19.8% |
5.54% |
-3.54% |
|
-3.72% |
|
ROA, % |
? |
|
-2.93% |
-0.50% |
-8.57% |
2.68% |
-1.74% |
|
-1.83% |
|
|
P/E |
? |
|
-28.6 |
0.00 |
0.00 |
17.7 |
-48.4 |
|
-44.6 |
|
P/FCF |
|
|
48.3 |
0.00 |
0.00 |
15.2 |
39.6 |
|
34.3 |
|
P/S |
? |
|
2.90 |
0.00 |
0.00 |
1.35 |
2.38 |
|
2.21 |
|
P/BV |
? |
|
-3.25 |
0.00 |
0.00 |
-2.99 |
-6.85 |
|
-7.46 |
|
EV/EBITDA |
? |
|
47.7 |
6.34 |
-24.2 |
6.61 |
21.8 |
|
19.0 |
|
Debt/EBITDA |
|
|
13.9 |
6.34 |
-24.2 |
2.59 |
5.14 |
|
4.72 |
|
|
R&D/CAPEX, % |
|
|
187.3% |
174.5% |
212.3% |
234.0% |
133.3% |
|
141.6% |
|
|
CAPEX/Revenue, % |
|
|
4.14% |
4.17% |
3.49% |
3.31% |
5.85% |
|
5.35% |
|
| Elanco Animal Health shareholders |
